Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-243
Closed -$249 481
2025
Q4
$249 Sell
243
-223
-48% -$70.7K ﹤0.01% 432
2025
Q3
$398 Buy
466
+65
+16% +$18.9K ﹤0.01% 406
2025
Q2
$330 Buy
401
+84
+26% +$23.8K ﹤0.01% 408
2025
Q1
$266 Buy
+317
New +$93.6K ﹤0.01% 430
2023
Q4
Sell
-47,230
Closed -$12.7M 350
2023
Q3
$12.7M Sell
47,230
-522
-1% -$130K 2.44% 11
2023
Q2
$10.6M Sell
47,752
-698
-1% -$162K 2.45% 13
2023
Q1
$11.7M Hold
48,450
2.64% 11
2022
Q4
$12.8M Buy
+48,450
New +$13M 3.09% 11

Other funds holding AMGN

Y.D. More Investments's AMGN Position: Q1 2026 in Review

Y.D. More Investments sold out of Amgen (AMGN) in Q1 2026, closing a stake of 243 shares — an estimated $249 sold.

Y.D. More Investments first reported a position in AMGN in Q4 2022 and held it in 8 quarters. The position peaked at $12.8M in Q4 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Y.D. More Investments reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Y.D. More Investments sold 243 Amgen shares in Q1 2026, an estimated $249.
  • Y.D. More Investments first reported a position in Amgen in Q4 2022 and held it in 8 quarters.
  • Y.D. More Investments's Amgen position peaked at $12.8M in Q4 2022.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Y.D. More Investments's 13F filing for Q1 2026, filed 4 May 2026.